Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AgeX Therapeutics Inc. (AGE)

  • Technical Exchange News
  • March 27, 2024, 00:24 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: AgeX Therapeutics, Inc. Common Stock.

Comment Full text

AgeX Therapeutics Inc. (AGE)

  • Technical Exchange News
  • March 27, 2024, 00:23 UTC
  • 34
  • 0 comments

IEXG symbol attribute type Security_Name was changed. Previous value: IEX Test Company Test Symbol Three for IEX. New value: AgeX Therapeutics, Inc. Common Stock.

Comment Full text

AgeX Therapeutics Inc. (AGE)

  • Technical Exchange News
  • March 27, 2024, 00:23 UTC
  • 33
  • 0 comments

IEXG symbol attribute type Test_mode was changed. Previous value: Y. New value: AgeX Therapeutics, Inc. Common Stock.

Comment Full text

Eterna Therapeutics Inc (ERNA)

  • Technical Exchange News
  • March 26, 2024, 18:56 UTC
  • 132
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Avid Bioservices Inc. (CDMO)

  • Technical Exchange News
  • March 26, 2024, 18:56 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Assertio Holdings Inc. (ASRT)

  • Technical Exchange News
  • March 26, 2024, 18:56 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eterna Therapeutics Inc (ERNA)

  • Technical Exchange News
  • March 26, 2024, 18:44 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Avid Bioservices Inc. (CDMO)

  • Technical Exchange News
  • March 26, 2024, 18:43 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Assertio Holdings Inc. (ASRT)

  • Technical Exchange News
  • March 26, 2024, 18:43 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Homology Medicines Inc (was merged with Q32 Bio Inc. (NASDAQ: QTTB) n 25/03/2024) (FIXX)

  • Technical Exchange News
  • March 26, 2024, 00:24 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Homology Medicines, Inc. - Common Stock. New value: Homology Medicines, Inc. - Common Stock.

Comment Full text
  • Previous
  • 740
  • 741
  • 742
  • 743
  • 744
  • Next

Search

News categories

  • Technical Exchange News(12022)
  • Event(5216)
  • SEC News(249354)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149833)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin